21st Annual Superbugs & Superdrugs Conference
21st Annual Superbugs & Superdrugs Conference
18th – 19th March 2019
London, UK
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections.
SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019. This year’s event aims to provide valuable insights and key updates on the latest developments within the scientific communities, as well as the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections.
The two-day conference will also host a diverse gathering of policy makers and economists, in addition to big pharmas and biotechs, who will discuss incentives, partnerships, regulations and new policies. Industry experts and scientific pioneers are set to present on their research advances and clinical data, as well as alternatives to antibiotics, such as monoclonal antibodies and antimicrobial peptides.
2019 HIGHLIGHTS:
- Analyse the current status of antimicrobial resistance with industry-led insight into current strategies to tackle AMR
- Hear about novel immune-therapeutics to target Gram-negative bacterial infections
- Learn about strategies to combat β-lactamases
- Evaluate the development of precision antibiotics: Agents designed to meet the demands of stewardship
- Explore the role of plasmids in the evolution of antimicrobial resistance
Join us in London next year to explore the challenges and solutions to the growing threat of antibiotic resistance, as well as take part in interactive roundtable discussions with leading organisations. Attendees will also have the exclusive opportunity of networking with an unrivalled gathering of senior experts from Chemical Biology Ventures, University of Oxford, MedImmune, HPRA, GARDP, DNDi, Bioharmony Therapeutics, and many more.
Early Bird Discounts!
Book by November 30th and save £400
Book by December 14th and save £200
Book by January 31st and save £100
For more information and to register online, please visit www.superbugssuperdrugs.com
